Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Dyne Therapeutics Inc (NASDAQ: DYN) was $17.77 for the day, down -2.68% from the previous closing price of $18.26. In other words, the price has decreased by -$2.68 from its previous closing price. On the day, 1.32 million shares were traded. DYN stock price reached its highest trading level at $18.72 during the session, while it also had its lowest trading level at $17.7.
Ratios:
Our analysis of DYN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.47 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Raymond James Upgraded its Outperform to Strong Buy on August 25, 2025, while the target price for the stock was maintained at $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 05 ’25 when Kerr Douglas bought 880 shares for $20.72 per share.
Cox John bought 2,662 shares of DYN for $55,150 on Dec 05 ’25. On Dec 05 ’25, another insider, Cox John, who serves as the CEO & President of the company, sold 2,662 shares for $20.72 each. As a result, the insider received 55,157 and left with 196,877 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2925870336 and an Enterprise Value of 1866573696.
Stock Price History:
The Beta on a monthly basis for DYN is 1.30, which has changed by 0.16219747 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $25.00, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is -11.43%, while the 200-Day Moving Average is calculated to be 27.85%.
Shares Statistics:
DYN traded an average of 2.85M shares per day over the past three months and 2019020 shares per day over the past ten days. A total of 142.61M shares are outstanding, with a floating share count of 118.92M. Insiders hold about 26.51% of the company’s shares, while institutions hold 83.07% stake in the company. Shares short for DYN as of 1765756800 were 14949400 with a Short Ratio of 5.24, compared to 1763078400 on 17111938. Therefore, it implies a Short% of Shares Outstanding of 14949400 and a Short% of Float of 9.98.
Earnings Estimates
The dynamic stock of Dyne Therapeutics Inc (DYN) is currently being evaluated by a team of 10.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.65 and low estimates of -$1.0.
Analysts are recommending an EPS of between -$3.39 and -$3.83 for the fiscal current year, implying an average EPS of -$3.55. EPS for the following year is -$3.32, with 12.0 analysts recommending between -$2.73 and -$4.32.
